Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
The Journal of Experimental Medicine|June 10, 2020
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppressionFrancis M Grant, Jie Yang, Rabab Nasrallah, et al.
Cytotherapy|April 24, 2021
Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustionKeli L Hippen, Scott N Furlan, Rahul Roychoudhuri, et al.
The Journal of Experimental Medicine|October 28, 2015
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infectionKyla D Omilusik, J Adam Best, Bingfei Yu, et al.
Cellular & Molecular Immunology|April 28, 2015
Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscapeJoseph G Crompton, Manikandan Narayanan, Suresh Cuddapah, et al.
Vaccine|December 3, 2014
Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiationRahul Roychoudhuri, Francois Lefebvre, Mitsuo Honda, et al.
Immunology|April 10, 2021
CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive functionSarah K Whiteside, Francis M Grant, David S Gyori, et al.
Nature Communications|January 24, 2024
Tumour-retained activated CCR7<sup>+</sup> dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activityColin Y C Lee, Bethany C Kennedy, Nathan Richoz, et al.
Cancer Research Communications|July 12, 2024
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist TherapyCharlotte J Imianowski, Paula Kuo, Sarah K Whiteside, et al.
The Journal of Clinical Investigation|March 4, 2020
IRF4 instructs effector Treg differentiation and immune suppression in human cancerGiorgia Alvisi, Jolanda Brummelman, Simone Puccio, et al.
Pageof 8